Benign esophageal epithelial hyperplasia can generally be cured, while malignant esophageal epithelial hyperplasia should be further pathologically biopsied in order to further develop a treatment plan, and whether it can be cured or not should not be generalized.
Diseases such as esophageal cancer, reflux esophagitis, or physiological factors can lead to esophageal epithelial hyperplasia, which refers to an increase in the number of cells in the esophageal mucosa, and the patient may experience hoarseness, retrosternal pain, and other symptoms. Pathological tissue biopsy can be performed to determine whether atypical hyperplasia exists in the location of esophageal hyperplasia, as well as the extent of the hyperplasia after taking samples from the location where the hyperplasia occurs.
Benign, mild esophageal lesions can be periodically reviewed without special treatment, and can be cured after reasonable treatment, while malignant esophageal epithelial hyperplasia can be treated with physical and surgical measures, and the treatment method, pathological staging of the patient, whether the resection is complete or not, and pathological typing and other factors can affect the treatment effect and survival of the patient.
It is recommended that patients with esophageal hyperplasia should go to the gastroenterology department or thoracic surgery department of regular hospitals for detailed consultation and treatment as prescribed.